July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Amer Zeidan Presents ASCERTAIN-V Study on All-Oral Therapy for AML at ASCO25
Jun 13, 2025, 06:48

Amer Zeidan Presents ASCERTAIN-V Study on All-Oral Therapy for AML at ASCO25

Amer Zeidan, Associate Professor of Medicine (Hematology) at the Yale University, posted on X:

“What a pleasure to present and usher a new era in AML with total oral therapy through ASCERTAIN-V study at ASCO25 All-Oral Regimen of Decitabine-Cedazuridine plus Venetoclax in Newly Diagnosed AML Ineligible for Intensive Induction Chemo.”

Read Further.

More about ASCO 2025 Symposium on OncoDaily.